航远 郭

Prof. 航远 郭


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Biochemical Pharmacology
Verified
Journal Article
Closed access
ZSZhenzhu Sun
Zhenzhu Sun
WLWenqiang Lu
Wenqiang Lu
NLNa Lin
Na Lin
HLHui Lin
Hui Lin
JZJie Zhang
Jie Zhang
航郭航远 郭
航远 郭

1 October 2021 in Circulation: Heart Failure
Verified
Journal Article
Closed access
PDF file
HLHui Lin
Hui Lin
LMLiping Meng
Liping Meng
ZSZhenzhu Sun
Zhenzhu Sun
SSShiming Sun
Shiming Sun
XHXingxiao Huang
Xingxiao Huang
航郭航远 郭
航远 郭
Background: Dietary polyphenols help to prevent cardiovascular diseases, and interactions between polyphenols and gut microbiota are known to exist. In this study, we speculated that gut microbiota-mediated metabolite regulation might contribute to the anticardiotoxic effects of yellow wine polyphenolic compound (YWPC) in doxorubicin (DOX)-treated rats. Methods: 16S-rDNA sequencing was performed to analyze the effects of YWPC on the gut microbiota in DOX-treated rats (n=6). Antibiotics were used to investigate the contribution of the altered microbiome to the role of YWPC (n=6). Plasma metabolomics were also analyzed by untargeted gas chromatography-mass spectrometry systems. Results: YWPC ameliorated DOX-mediated cardiotoxicity, as evidenced by increased cardiac and mitochondrial function and reduced levels of inflammation and myocardial apoptosis ( P <0.05 for all). The low abundance of Escherichia – Shigella , Dubosiella , and Allobaculum , along with enrichment of Muribaculaceae_unclassified , Ralstonia , and Rikenellaceae_RC9_gut_group in the gut, suggested that YWPC ameliorated DOX-induced microbial dysbiosis. YWPC also influenced the levels of metabolites altered by DOX, resulting in lower arachidonic acid and linoleic acid metabolism and higher tryptophan metabolite levels ( P <0.05 for all). Correlational studies indicated that YWPC alleviated DOX-induced inflammation and mitochondrial dysfunction by modulating the gut microbial community and its associated metabolites. Antibiotic treatment exacerbated cardiotoxicity in DOX-treated rats, and its effect on the gut microbiota partly abolished the anticardiotoxic effects of YWPC, suggesting that the microbiota is required for the cardioprotective role of YWPC. Conclusions: YWPC protected against DOX-induced cardiotoxicity in a gut microbiota–dependent manner. This supports the use of dietary polyphenols as a therapeutic approach for the treatment of cardiovascular diseases via microbiota regulation.

1 October 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JZJie Zhang
Jie Zhang
ZSZhenzhu Sun
Zhenzhu Sun
NLNa Lin
Na Lin
WLWenqiang Lu
Wenqiang Lu
XHXingxiao Huang
Xingxiao Huang
JCJufang Chi
Jufang Chi
Doxorubicin (DOX) is well-known for its potent antitumor activity but limited by its multiple and serious adverse effects. A major adverse effect is acute cardiotoxicity; yet, its mechanism has not been elucidated. Fucoidan is a multifunctional and nontoxic polysaccharide that is widely studied because of its favorable biological activities and safety. Hence, we proposed that fucoidan may play a protective role in DOX-induced acute cardiotoxicity without causing additional side effects. Sprague-Dawley rats were injected intraperitoneally with a single high dose of DOX to induce acute cardiac injury. Fucoidan was administered orally before DOX injection and AG490, a JAK2 inhibitor, was applied to verify the participation of the JAK2/STAT3 pathway. In vitro, H9C2 cells were treated with the same drugs at different concentrations and intervention times. in vivo and in vitro results demonstrated that DOX administration induced myocardial damage accompanied by acceleratory apoptosis and deficient autophagy in heart tissues or cells, which could be significantly improved by fucoidan supplement. AG490 partly abolished the cardioprotective effects of fucoidan, suggesting the involvement of JAK2 signaling. Additionally, western blotting revealed DOX-induced JAK2/STAT3 pathway activation, which was enhanced by fucoidan and weaken by AG490. Hence, fucoidan exerted a favorable effect on DOX-induced cardiotoxicity by enhancing autophagy and suppressing apoptosis in a JAK2/STAT3-dependent manner, which may provide a promising and novel therapeutic strategy against negative chemotherapy-induced effects.

24 November 2022 in Biochemical Pharmacology
Verified
Journal Article
Closed access
ZSZhengzhu Sun
Zhengzhu Sun
CFChongfeng Fang
Chongfeng Fang
SXShasha Xu
Shasha Xu
BWBin Wang
Bin Wang
DLDanlei Li
Danlei Li
JJJianjun Jiang
Jianjun Jiang

29 July 2022 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
HZHanlin Zhang
Hanlin Zhang
JWJingfan Weng
Jingfan Weng
SSShimin Sun
Shimin Sun
JZJiedong Zhou
Jiedong Zhou
QYQi Yang
Qi Yang
航郭航远 郭
航远 郭

6 October 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
ZZZuoquan Zhong
Zuoquan Zhong
YGYefei Gao
Yefei Gao
JZJiedong Zhou
Jiedong Zhou
FWFang Wang
Fang Wang
PZPeipei Zhang
Peipei Zhang
航郭航远 郭
航远 郭
Doxorubicin (DOX) is a commonly used chemotherapy drug widely applied in various cancers such as breast cancer, leukemia, and sarcomas. However, its usage is limited by cardiotoxicity. Additionally, the cardiac toxicity of DOX accumulates with dose and duration, making it imperative to identify therapeutic targets for DOX-induced cardiomyopathy (DIC). It has been reported that miRNAs are involved in the progression of DIC. Mir-34a-5p has been identified as an early diagnostic marker for DIC. While studies have shown the involvement of mir-34a-5p in DIC apoptosis, it has not been validated in animal models, nor has the potential improvement of DIC by inhibiting mir-34a-5p been confirmed. Autophagy and pyroptosis are key factors in the development of DIC and can serve as therapeutic targets for its treatment. In this study, we found that mir-34a-5p was upregulated in the heart after DOX treatment and that the inhibition of mir-34-5p reduced autophagy and pyroptosis in DIC. We also found that the inhibition of mir-34a-5p inhibited pyroptosis by regulating autophagy and reducing mitochondrial reactive oxygen species. Moreover, we identified Sirtuin3 (Sirt3) as a target gene of mir-34a-5p using a double-luciferase reporter assay. overexpression Sirt3 reduced pyroptosis by alleviating autophagy. Our research findings suggest that inhibiting mir-34a-5p has a beneficial role in alleviating autophagy and pyroptosis in DIC. This provides therapeutic prospects for treating DIC.